These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 33561633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibiotic use during cytarabine consolidation in acute myeloid leukemia.
    Vale CA, Egan PC, Ingham R, Farmakiotis D, Reagan JL.
    Ann Hematol; 2021 Jan; 100(1):79-84. PubMed ID: 32870366
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients.
    Ciftciler R, Demiroglu H, Buyukasık Y, Okay M, Aksu S, Sayınalp N, Malkan UY, Haznedaroglu IC, Ozcebe O, Goker H.
    Transfus Apher Sci; 2018 Dec; 57(6):752-755. PubMed ID: 30249531
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics.
    Zhou JH, Lin HQ, Shen Q, Hu LN, Li GQ, Sun XF, Zhang XY.
    Curr Med Sci; 2018 Feb; 38(1):51-57. PubMed ID: 30074151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.
    Miyamoto T, Nagafuji K, Fujisaki T, Uchida N, Matsue K, Henzan H, Ogawa R, Takase K, Aoki T, Hidaka M, Teshima T, Taniguchi S, Akashi K, Harada M, Japan Study Group for Cell Therapy and Transplantation (JSCT).
    Int J Hematol; 2018 Apr; 107(4):468-477. PubMed ID: 29243031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High Dose Cytosine Arabinoside in the consolidation of adult acute myeloid leukemia.
    Rahman MH, Khan MA, Islam MS, Afrose S, Ara T.
    Mymensingh Med J; 2012 Apr; 21(2):213-9. PubMed ID: 22561761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines.
    Kim DS, Kang KW, Lee SR, Park Y, Sung HJ, Kim SJ, Choi CW, Kim BS.
    Ann Hematol; 2015 Sep; 94(9):1485-92. PubMed ID: 25944346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis.
    Magina KN, Pregartner G, Zebisch A, Wölfler A, Neumeister P, Greinix HT, Berghold A, Sill H.
    Blood; 2017 Aug 17; 130(7):946-948. PubMed ID: 28679736
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.